期刊文献+

内皮功能紊乱与冠心病致病机制研究进展 被引量:10

Advancement about the Research of Endothelial Dysfunction and Pathogenic Mechanism Coronary Heart Disease
下载PDF
导出
摘要 近年来,内皮功能紊乱与冠心病之间的关系越来越来受到重视。内皮功能紊乱存在于冠心病的发生、发展中,甚至存在于冠心病发病之前。深入了解内皮功能紊乱与冠心病之间的关系,能够为减少冠心病急性事件的发生和降低患者病死率提供新思路、新方法。 In recent years, the relationship between endothelial dysfunction and coronary heart disease has been paled more and more attention. Endothelial dysfunction can be fnund in the process of the disease , or even exist before the occurrence of the disease. Further understanding of the relationship between them can provide new methods in reducing the incidence of acute case in coronary heart disease and decreasing the its mortality.
出处 《医学综述》 2006年第4期207-209,共3页 Medical Recapitulate
关键词 冠心病 内皮功能紊乱 机制 Endothelial dysfunction Coronary heart disease Mechanism
  • 相关文献

参考文献16

  • 1Verma S, Anderson TJ. Fundamentals of endothelial function forthe clinical cardiologist[J]. Circulation,2002,105(5) :546-549. 被引量:1
  • 2Stanger O, Weger M. Interactions of homocysteine, nitric oxide, folate andradicals in the progressively damaged endothelium[ J]. Clin Chem Lab Med,2003,41 ( 11 ) : 1444-1454. 被引量:1
  • 3Tofler GH, D' Agostino RB, Jacques PF. Association between increased homocysteine levels and impaired fibrinolytic potential:potential mechanism for cardiovascular risk [ J ]. Thromb Haemost, 2002,88 (5) :799-804. 被引量:1
  • 4Moat SJ, Lang D, Me Dowell IF. Folate homocysteine endothelial function and cardiovascular disease [ J ]. J Nutr Biochem, 2004, 15 (2) : 64-79. 被引量:1
  • 5张宝娓,汪波,姚兴海,张永刚,曹军,张钧华,唐朝枢.动脉粥样硬化家兔主动脉壁与红细胞L精氨酸/一氧化氮系统变化[J].中华心血管病杂志,2002,30(5):302-304. 被引量:19
  • 6Iihling C, Szombathy T, Bohrmann B. Coexpression of endothelin-converting enzyme and endothelin-1 in different stages of human atherosclerosis [ J ]. Circulation, 2001,104 (8) : 864-869. 被引量:1
  • 7Ihling C, Bohrmann B, Schaefer HE, et al. Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis-novel targets for pharmacotherapy in atherosclerosis [ J ]. Curr Vase Pharmacol, 2004,2 ( 3 ) : 249-258. 被引量:1
  • 8Laws PE, Spark JI, Cowled PA. The role of statins in vascular disease [J] .Eur Jvasc Endovsc Surg,2004,279(1) :6-16. 被引量:1
  • 9Wassman S, Faul A, Hennen B, et al. Rapid effect of 3-hydroxy-3-methlgiutaryl coenzyme a reductase inhibition on coronary endothelial function[J]. Cire Res,2003,93(9) :e98-e103. 被引量:1
  • 10Laufs U, Gertz K, Dirnagl U, et al. Rosuvastatin, a new HMG-CoA reductaseinhibitor, Upregulates endothelial nitric oxide synthase and protects from ischemic stroke inmice[ J]. Brain Res, 2002,942(122) :23-30. 被引量:1

二级参考文献8

  • 1祖虹 祁芸芸.原发性高血压血管内皮功能及红细胞L-Arg/NO系统的研究[J].北京医科大学学报,2000,32:557-560. 被引量:1
  • 2Aidu P S, Singh A, Kulkarni S K. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms. Br J Pharmacol, 2002, 136:193-200. 被引量:1
  • 3Celermajer D S,Sorensen K,Ryalls M,et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet,1992,390:1111-1115. 被引量:1
  • 4Huggins G S,Pasernak P C, Alpert N M,et al. Effectsof short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation,1998,98:1291-1296. 被引量:1
  • 5Feuerstein G Z, Ruffolo R R Jr. Carvedilol, a novel vasodilating with the potential for cardiovascular organ protection. Eur Heart J, 1996, 17 (Suppl B): 24-29. 被引量:1
  • 6Matsuda Y,AkitaH,TerashimaM, et al. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease .Am Heart J,2000, 140:753-759. 被引量:1
  • 7张新波,黄海鹭,张灵芝,李倩虹,张晨晖,汤健.一氧化氮合成酶(NOS)活性的测定及其应用[J].北京大学学报(医学版),1994,32(S1):173-176. 被引量:39
  • 8林玲,黄春涛,石延科,苗云波,马德林.卡维地洛治疗急性心肌梗死与及其抗氧自由基的临床研究[J].临床心血管病杂志,2002,18(3):120-121. 被引量:2

共引文献19

同被引文献152

引证文献10

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部